Welcome to LookChem.com Sign In|Join Free
  • or
4-Fluoro-7-Methoxy-1-indanone is a chemical compound characterized by its molecular formula C10H9FO2. It presents as a white to off-white crystalline powder with a molecular weight of 182.17 g/mol. 4-Fluoro-7-Methoxy-1-indanone is notable for its role in the synthesis of pharmaceutical and agrochemical products, as well as its potential as a precursor in the production of other organic compounds. Its applications extend to research and development within the realms of medicinal chemistry and drug discovery, necessitating careful handling and adherence to safety protocols.

127033-13-0

Post Buying Request

127033-13-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

127033-13-0 Usage

Uses

Used in Pharmaceutical and Agrochemical Industries:
4-Fluoro-7-Methoxy-1-indanone is utilized as a reagent in the synthesis of various pharmaceutical and agrochemical products, contributing to the development of new drugs and agricultural chemicals.
Used in Research and Development:
In the fields of medicinal chemistry and drug discovery, 4-Fluoro-7-Methoxy-1-indanone serves as a valuable precursor, enabling the exploration of novel chemical entities and potential therapeutic agents.
Used as a Precursor in Organic Chemistry:
4-Fluoro-7-Methoxy-1-indanone is employed as a precursor in the production of other organic compounds, facilitating the creation of diverse chemical structures for various applications.

Check Digit Verification of cas no

The CAS Registry Mumber 127033-13-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,7,0,3 and 3 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 127033-13:
(8*1)+(7*2)+(6*7)+(5*0)+(4*3)+(3*3)+(2*1)+(1*3)=90
90 % 10 = 0
So 127033-13-0 is a valid CAS Registry Number.

127033-13-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-fluoro-7-methoxy-2,3-dihydroinden-1-one

1.2 Other means of identification

Product number -
Other names 4-Fluoro-7-methoxy-2,3-dihydro-1H-inden-1-one

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:127033-13-0 SDS

127033-13-0Relevant academic research and scientific papers

Design, synthesis, and characterization of oxadiazolopyrazine analogs with application as anticancer agents

Chen, Wei-Chia,Chen, Chia-Ling,Chang, Tzu-Ting,Hsieh, Feng-Chun,Chen, Wei-Sheng,Li, Wen-Shan

, p. 375 - 387 (2021/12/23)

Here, we describe the synthesis and evaluation of a class of cell-permeable indeno-oxadiazolopyrazine analogs as the anticancer agents. A new and facile approach to the synthesis of substituted analogs of indeno-oxadiazolopyrazine is illustrated. We find that the designed indeno-oxadiazolopyrazines, 3, 4, 10, 11, 15, and 16, act as potent anticancer agents compared to camptothecin, topoisomerase I inhibitor. These observations suggest that the electron-donating group (methoxy) at the C-5, C-6, and C-8 positions or electron-withdrawing group (fluoro) at the C-6 and C-7 positions on the A ring of indeno-oxadiazolopyrazines is required for antiproliferative activities against MDA-MB-231, BT549, and MCF7 cell lines.

Bicyclic amino-substituted compounds

-

, (2008/06/13)

A compound of formula (I), wherein X is O, CH 2, S, SO or SO 2 ; R is F or Cl; R 1 is H, C 1 -C 6 alkyl or C 2 -C 6 alkenyl; R 2 is H, C 1 -C 6 alkyl or C 2 -C 6 alkenyl; R 3 is H, C 1 -C 6, alkyl, a pharmaceutically acceptable salt thereof, an enantiomer thereof, and a pharmaceutically acceptable salt of said enantiomer for use in therapy. A pharmaceutical preparation containing as active ingredient any one of said compounds. A process for the preparation of a compound of formula (I).

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 127033-13-0